Article by:
Beth Ann Mayer
Ozempic and Wegovy have been called game-changers for people living with obesity or overweight.
One 2021 clinical trial Trusted Source indicated that 86.2% of more than 800 participants achieved “clinically significant” weight loss after taking 2.4 mg weekly doses of semaglutide (sold under the brand names Ozempic and Wegovy) for 68 weeks. Read the full article...
Google